8-K: Healthcare Realty Boosts Outlook on Strong Q3 Performance

Healthcare Realty Trust reported robust third-quarter results, exceeding prior guidance with strong same-store NOI growth and proactive balance sheet management.

Summary

• Reported a GAAP Net Loss of $(0.17) per share for Q3 2025, an improvement from $(0.26) per share in Q3 2024.
• Achieved NAREIT FFO of $0.34 per share and Normalized FFO of $0.41 per share for the third quarter.
• Funds Available for Distribution (FAD) reached $116.9 million, with a payout ratio of 73%.
• Same store cash Net Operating Income (NOI) grew by an impressive 5.4%, driven by a 90 basis point occupancy increase and 88.6% tenant retention.
• Cash leasing spreads were positive at +3.9% for the quarter.
• Increased 2025 guidance for Normalized FFO per share to $1.59 $1.61 and same store cash NOI growth to 4.00% 4.75%.
• Executed 1.6 million square feet of leases, including 441,000 square feet of new leases, with a weighted average lease term of 5.8 years and an average annual escalator of 3.1%.
• Completed $404 million in asset sales through 15 transactions during Q3 and through October, bringing year-to-date sales to $486 million at a blended 6.5% cap rate.
• Approximately $700 million of additional sales are under contract or Letter of Intent (LOI).
• Reduced run-rate Net Debt to Adjusted EBITDA to 5.8x, with an anticipation of 5.4x to 5.7x by year-end.
• Maintained approximately $1.3 billion of liquidity through October and fully repaid a $151 million term loan due May 2027.
• Declared a common stock dividend of $0.24 per share, payable on November 21, 2025.

Sentiment

Score: 8

Explanation: The company delivered strong operational results, particularly in same-store NOI growth and leasing activity. The increased full-year guidance for key metrics, coupled with proactive balance sheet management through significant asset dispositions and debt repayment, indicates a positive trajectory and strong financial health. While a GAAP net loss was reported, the FFO and FAD metrics, which are more relevant for REITs, show solid performance.

Positives

• Strong 5.4% same store cash NOI growth, exceeding the prior guidance range.
• Increased 2025 guidance for Normalized FFO per share and same store cash NOI growth, indicating improved outlook.
• Significant asset dispositions totaling $404 million, contributing to debt reduction and portfolio optimization.
• Proactive debt management, including the full repayment of a $151 million term loan, improving the balance sheet.
• Healthy tenant retention rate of 88.6% and positive cash leasing spreads of 3.9%.
• Active development and redevelopment pipeline, with projects like Fort Worth (72% leased) advancing well.
• Maintained substantial liquidity of approximately $1.3 billion.

Negatives

• Reported a GAAP Net Loss of $(0.17) per share, although an improvement year-over-year, it still represents a loss under GAAP.
• Incurred significant impairment charges on real estate assets and credit loss reserves totaling $(104,362) thousand in Q3 2025.

Risks

• Expected results may not be achieved due to various market conditions and operational factors.
• Uncertainty regarding future financial performance and results of the company.
• Potential impacts from pandemics or other health crises on operations and tenant performance.
• Risks associated with increases in interest rates, affecting borrowing costs and property valuations.
• Availability and cost of capital at expected rates may fluctuate.
• Intense competition for quality assets in the medical outpatient building market.
• Negative developments in the operating results or financial condition of tenants, including their ability to pay rent.
• Challenges in repositioning or selling facilities with profitable results.
• Difficulty in releasing space at similar rates as vacancies occur or renewing expiring leases.
• Impact of government regulations on tenants' Medicare and Medicaid reimbursement rates and operational requirements.
• Unanticipated difficulties and/or expenditures related to future acquisitions and developments.
• Changes in rules or practices governing the company's financial reporting.
• Potential requirements under purchase options to sell properties, with no assurance of reinvesting proceeds at equal rates of return.
• Uninsured or underinsured losses related to casualty or liability events.
• Incurrence of additional impairment charges on real estate properties or other assets.
• Other legal and operational matters not explicitly detailed.

Future Outlook

The company increased its 2025 guidance for Normalized FFO per share to a range of $1.59 $1.61, up from the prior range of $1.57 $1.61. Same Store Cash NOI growth guidance was also raised to 4.00% 4.75% from the previous 3.25% 4.00%. The company anticipates its run-rate Net Debt to Adjusted EBITDA to be between 5.4x and 5.7x by year-end. Approximately $700 million of additional asset sales are under contract or LOI, with a significant Richmond, VA portfolio sale expected to close in the fourth quarter.

Industry Context

As the largest pure-play owner, operator, and developer of medical outpatient buildings in the United States, Healthcare Realty Trust's performance reflects the ongoing demand for healthcare real estate, particularly facilities located on or adjacent to major hospital campuses. The strategic dispositions of non-core assets and market exits (e.g., Milwaukee, Chicago, Richmond) indicate a focus on optimizing portfolio quality and concentrating investments in high-growth, high-value markets. The active development and redevelopment pipeline aligns with broader industry trends of modernizing healthcare infrastructure to meet evolving patient and provider needs, enhancing the value proposition of medical office buildings.

Related Party Transactions

• Monetization of three off-campus MOBs in Columbus, OH, sold to the affiliated health system for $34 million.
• Strategic market exit of Milwaukee MSA with the $60 million sale of two MOBs to the affiliated health system.
• Opportunistic sale of a fully stabilized asset in Tampa, FL, to the affiliated health system at a premium valuation of $22 million.
• Sale of four on-campus properties in Dallas, TX, to the affiliated health system for $59 million.

Stakeholder Impact

• Shareholders: Positive impact due to increased guidance, strong operational performance, and a consistent dividend payout. Improved leverage ratios enhance financial stability.
• Tenants: Benefit from new lease executions, high retention rates, and investments in modern outpatient facilities through redevelopment projects.
• Creditors: Positive impact from significant debt paydown, improved leverage metrics, and enhanced liquidity, reducing credit risk.
• Employees: Normalizing items include restructuring and severance-related costs, indicating potential impacts on some employees, though specific details are not provided.

Next Steps

• Host an earnings conference call on Friday, October 31, 2025, at 9:00 a.m. Eastern Time.
• Pay a common stock dividend of $0.24 per share on November 21, 2025.
• Complete the sale of six fully-leased MOBs in Richmond, VA, expected to close in the fourth quarter of 2025.
• Continue progress on the development and redevelopment pipeline across major markets.
• Work towards achieving a Net Debt to Adjusted EBITDA ratio between 5.4x and 5.7x by year-end.

Key Dates

Recommendation

The company's strong third-quarter operational performance, highlighted by robust same-store cash NOI growth and healthy leasing activity, demonstrates effective asset management. The upward revision of full-year guidance for both Normalized FFO per share and same-store cash NOI growth signals management's confidence in continued positive momentum. Furthermore, the strategic asset dispositions and proactive debt reduction efforts significantly strengthen the balance sheet and improve leverage metrics, enhancing financial flexibility. These factors collectively present a compelling investment case for long-term growth and stability in the healthcare REIT sector.

Keywords

Healthcare Realty Trust, HR, REIT, Medical Office Buildings, MOB, Q3 2025 Earnings, FFO, Normalized FFO, NOI Growth, Asset Dispositions, Debt Reduction, Real Estate Investment Trust, Healthcare Real Estate, Dividend, Guidance Update